Delivery Order SPE2DB24D2003-SPE2DB25FXKX2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,517.23 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhaler (12 grams) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,766.80 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a $9,867 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,524.46 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 mcg inhaler, 12 gm. This order, which has an ultimate completion date of October 11, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The IDC, held by AmerisourceBergen, enables the DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.90 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 grams) with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $2,646.36 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm), with an ultimate completion date of June 13, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.54 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (8 grams) with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXKX2Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,900.89 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhaler (12 grams) under a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of July 23, 2025, one day after the award date of July 22, 2025. Performance will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The underlying IDC enables the company to furnish a diverse range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/22/25 |